JP2024544211A5 - - Google Patents

Info

Publication number
JP2024544211A5
JP2024544211A5 JP2024533255A JP2024533255A JP2024544211A5 JP 2024544211 A5 JP2024544211 A5 JP 2024544211A5 JP 2024533255 A JP2024533255 A JP 2024533255A JP 2024533255 A JP2024533255 A JP 2024533255A JP 2024544211 A5 JP2024544211 A5 JP 2024544211A5
Authority
JP
Japan
Prior art keywords
health
strain
infections
bacillus coagulans
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544211A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081195 external-priority patent/WO2023108080A1/en
Publication of JP2024544211A publication Critical patent/JP2024544211A/ja
Publication of JP2024544211A5 publication Critical patent/JP2024544211A5/ja
Pending legal-status Critical Current

Links

JP2024533255A 2021-12-08 2022-12-08 バチルス・コアギュランス(bacillus coagulans)株、その組成物及び使用の方法 Pending JP2024544211A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE2021/0210 2021-12-08
IE20210210 2021-12-08
PCT/US2022/081195 WO2023108080A1 (en) 2021-12-08 2022-12-08 Bacillus coagulans strain, compositions thereof, and methods of use

Publications (2)

Publication Number Publication Date
JP2024544211A JP2024544211A (ja) 2024-11-28
JP2024544211A5 true JP2024544211A5 (https=) 2025-12-12

Family

ID=85037144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533255A Pending JP2024544211A (ja) 2021-12-08 2022-12-08 バチルス・コアギュランス(bacillus coagulans)株、その組成物及び使用の方法

Country Status (10)

Country Link
US (1) US20250161374A1 (https=)
EP (1) EP4444860A1 (https=)
JP (1) JP2024544211A (https=)
KR (1) KR20240145457A (https=)
CN (1) CN119421944A (https=)
AU (1) AU2022407528A1 (https=)
CA (1) CA3239842A1 (https=)
MX (1) MX2024006844A (https=)
WO (1) WO2023108080A1 (https=)
ZA (1) ZA202404359B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117603847B (zh) * 2023-10-30 2024-05-14 无锡爱科派生物科技有限公司 一株凝结魏茨曼氏菌及其在重金属吸附中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160838B2 (en) * 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions

Similar Documents

Publication Publication Date Title
JP2024546089A5 (https=)
Stavropoulou et al. Probiotics in medicine: a long debate
Zhou et al. Lactobacillus plantarum ZJ316 attenuates Helicobacter pylori-induced gastritis in C57BL/6 mice
Khalighi et al. Probiotics: A Comprehensive Review of Their
US10155015B2 (en) Probiotic compositions for use in the treatment of bowel diseases
Wang et al. Influence of Lactobacillus fermentum I5007 on the intestinal and systemic immune responses of healthy and E. coli challenged piglets
CN101048168B (zh) 用于改善的阴道健康的益生菌乳杆菌属菌株
TWI574633B (zh) 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物
Jeronymo-Ceneviva et al. Probiotic properties of lactic acid bacteria isolated from water-buffalo mozzarella cheese
JP6587614B2 (ja) プロバイオティクスとしてのラクトバチルス属の菌株
Marteau et al. Probiotics and health: new facts and ideas
Nader‐Macías et al. Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract
RU2004130876A (ru) Штаммы lactobacillus
CN103764154A (zh) 包含片球菌属的药物组合物和减轻胃肠综合征的症状的方法
EP4009995B1 (en) Probiotic mixture
AU2019379234B2 (en) Strains, composition and method of use
KR101734960B1 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 류코노스톡 홀잡펠리 균주 및 이를 포함하는 조성물
JP2024546089A (ja) バチルス・メガテリウム(Bacillus megaterium)株、その組成物及び使用の方法
JP2024539315A (ja) 腸内マイクロバイオーム調節のためのプロバイオティクス組成物
JP2024544211A5 (https=)
JP2024545064A5 (https=)
Nagaraj et al. Probiotics and oral health
JP5209294B2 (ja) インターロイキン12産生促進剤
ES2891536T3 (es) Cepa Bifidobacterium animalis AMT30 y composición que contiene la cepa de Bifidobacterium animalis AMT30
LeBlanc et al. Mechanisms involved in the anti-inflammatory properties of native and genetically engineered lactic acid bacteria